Randomized Study Comparing Transcatheter Arterial Microembolization and Corticosteroid Injection with Physical Therapy for Frozen Shoulder Treatment

What this Trial Is About

Researchers are evaluating the effectiveness of two treatments for frozen shoulder, a condition that causes pain and limits shoulder movement. This study compares transcatheter arterial microembolization TAME, a newer technique targeting abnormal blood vessels and inflammation, with corticosteroid injections, which provide short-term pain relief. The trial is a randomized controlled study conducted at a single center aiming to address the lack of direct comparison between these therapies. Participants will be randomly assigned to one of two groups. One group will receive a single TAME treatment involving embolization of abnormal shoulder blood vessels under local anesthesia. The other group will receive two corticosteroid injections into the shoulder joint and subacromial bursa spaced two weeks apart. Both groups will undergo physical therapy three times a week for four weeks. Treatments focus on improving pain and shoulder function. Participants will have clinical assessments at the start and at 1, 2, 4, and 6 months after treatment begins. These include pain and disability questionnaires, shoulder range of motion tests, quality of life surveys, and patient evaluations of treatment effect. The study will monitor safety and compare long-term outcomes over six months. Researchers will analyze data to identify factors that predict better treatment responses, helping guide future care for frozen shoulder.

Comparison of Transcatheter Arterial Microembolization and Corticosteroid Injection and for Treatment of Frozen Shoulder